HTR2A Gene

📖 Wiki Page

gene1361 wordssynced 2026-04-02

HTR2A Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">HTR2A — Serotonin Receptor 2A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>HTR2A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>5-Hydroxytryptamine Receptor 2A</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>13q14.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3352" target="_blank">3352</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102468" target="_blank">ENSG00000102468</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P28223" target="_blank">P28223</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Schizophrenia](/diseases/schizophrenia), [Depression](/diseases/depression), [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cortex, Platelets, Smooth muscle, Olfactory bulb</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td

...

HTR2A Gene

HTR2A — Serotonin Receptor 2A

Introduction

Htr2A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

HTR2A (5-Hydroxytryptamine Receptor 2A) encodes the 5-HT2A serotonin receptor, a G protein-coupled receptor (GPCR) that activates phospholipase C signaling cascades. It is widely expressed throughout the central nervous system and is the primary molecular target of psychedelic drugs (LSD, psilocybin, DMT) and atypical antipsychotics["@nichols2012"]. The 5-HT2A receptor plays critical roles in mood regulation, cognition, perception, and sleep-wake cycles, making it a key therapeutic target for neuropsychiatric disorders.

Receptor Structure

The HTR2A-encoded protein possesses the classic seven-transmembrane domain structure of GPCRs:

Extracellular N-terminus: Contains glycosylation sites important for receptor folding and trafficking
Transmembrane domains: Seven hydrophobic alpha-helices that form the ligand-binding pocket
Third intracellular loop: Contains the G protein coupling interface
C-terminal tail: Contains serine/threonine phosphorylation sites for desensitization and arrestin binding

The receptor exists as both monomers and dimers, with heterodimerization with other serotonin receptors (particularly 5-HT2C) influencing pharmacological properties and signaling.

Signal Transduction

HTR2A activates the Gq/11 protein signaling pathway:

Agonist binding induces conformational change

Gq/11 activation stimulates phospholipase C-beta (PLCβ)

PIP2 hydrolysis generates:

DAG (diacylglycerol) → activates protein kinase C (PKC)
IP3 (inositol trisphosphate) → releases calcium from ER stores

4. Downstream effects include:

Calcium-dependent neuronal excitation
PKC-mediated phosphorylation of ion channels and transcription factors
CREB activation and gene expression changes

Normal Physiological Functions

Central Nervous System

Cortical processing: 5-HT2A receptors in layer V pyramidal [neurons](/entities/neurons) modulate cortical output and plasticity
Perception: Critical for psychedelic drug effects and normal sensory processing
Mood regulation: Antagonist activity contributes to antidepressant efficacy
Sleep-wake cycles: Regulates REM sleep and arousal states
Thermoregulation: Central 5-HT2A signaling modulates body temperature

Peripheral Tissues

Platelets: Major serotonin receptor mediating platelet aggregation
Smooth muscle: Vasoconstriction in blood vessels, gastrointestinal motility
Olfactory bulb: Modulates olfactory sensory processing

Brain Region Distribution

HTR2A exhibits distinct regional expression patterns:

| Brain Region | Expression Level | Functional Implications |
|--------------|-----------------|----------------------|
| Prefrontal [cortex](/brain-regions/cortex) | High | Cognitive processing, working memory |
| Primary sensory cortex | High | Sensory gating, integration |
| Claustrum | Very high | Consciousness, integration |
| Olfactory bulb | High | Olfactory processing |
| [Hippocampus](/brain-regions/hippocampus) | Moderate | Memory, emotional processing |
| Thalamus | Moderate | Sensory relay modulation |
| Brainstem raphe | Low | Autoregulation |

Disease Associations

Schizophrenia

The 5-HT2A receptor is central to schizophrenia pathophysiology and treatment:

Atypical antipsychotics: Clozapine, risperidone, olanzapine primarily work through 5-HT2A antagonism
A/A genotype: rs6313 polymorphism associated with improved treatment response
Pyramidal neuron dysfunction: Altered 5-HT2A signaling contributes to cortical hypofrontality
Hallucinations: 5-HT2A overactivation may contribute to psychotic symptoms[@gonzalezmaeso2007]

Major Depressive Disorder

5-HT2A receptors are implicated in depression and antidepressant action:

Antagon: Trazodone,ist efficacy mirtazapine, and atypical antipsychotics have 5-HT2A antagonist activity
SSRIs and 5-HT2A: Chronic SSRI use leads to 5-HT2A downregulation correlating with therapeutic response
Treatment-resistant depression: 5-HT2A agonists may have rapid antidepressant effects (psilocybin trials)[@carhartharris2021]
Post-SSRI sexual dysfunction: 5-HT2A activation contributes to sexual side effects

Parkinson's Disease

5-HT2A signaling influences both motor and non-motor symptoms:

L-DOPA-induced dyskinesias: 5-HT2A antagonists reduce dyskinesia severity in preclinical models
Parkinson's psychosis: 5-HT2A overactivity contributes to visual hallucinations
Sleep disorders: Altered 5-HT2A signaling affects REM sleep behavior disorder
Depression in PD: Serotonergic dysfunction including 5-HT2A contributes to mood symptoms[@huot2012]

Alzheimer's Disease

5-HT2A changes are observed throughout AD progression:

Cortical loss: 5-HT2A receptor density decreases in AD cortex
Behavioral and psychological symptoms of dementia (BPSD): 5-HT2A alterations contribute to agitation, anxiety, depression
Amyloid interaction: [Aβ](/proteins/amyloid-beta) oligomers can modulate 5-HT2A signaling
Therapeutic targeting: 5-HT2A modulators may help manage BPSD

Other Neurological Conditions

Migraine: 5-HT2A mediates vasoconstriction in migraine treatment (triptans are 5-HT1B/1D agonists)
Epilepsy: Altered 5-HT2A expression in seizure disorders
Anxiety disorders: 5-HT2A antagonists have anxiolytic potential

Therapeutic Implications

Current Therapeutics

| Drug Class | Examples | Mechanism | Application |
|-----------|----------|-----------|-------------|
| Atypical antipsychotics | Clozapine, risperidone | 5-HT2A antagonism + D2 antagonism | Schizophrenia, psychosis |
| Antidepressants | Trazodone, mirtazapine | 5-HT2A antagonism | Depression, insomnia |
| Migraine triptans | Sumatriptan, rizatriptan | 5-HT1B/1D agonist | Acute migraine |

Psychedelic-Assisted Therapy

Psilocybin and other 5-HT2A agonists show promise in:

Treatment-resistant depression: Phase 2 trials show rapid and sustained effects
Anxiety and depression in cancer patients: FDA breakthrough therapy designation
Addiction: Clinical trials for smoking cessation and alcohol use disorder
Mechanism: Rapid neural plasticity through 5-HT2A activation and [mTOR](/entities/mtor) signaling[@ly2018]

Drug Development Challenges

Hallucinogenic effects: Therapeutic use requires non-hallucinogenic analogs
Cardiovascular effects: Peripheral 5-HT2A causes vasoconstriction
Temporal dynamics: Receptor desensitization and internalization patterns

Key Publications

Nichols DE, et al. (2012). 'Psychedelic 5-HT2A receptors.' Pharmacological Reviews. PMID: 22293759(https://pubmed.ncbi.nlm.nih.gov/22293759/)

Gonzalez-Maeso J, et al. (2007). 'Hallucination and schizophrenia.' Neuron. PMID: 17698010(https://pubmed.ncbi.nlm.nih.gov/17698010/)

Carhart-Harris RL, et al. (2021). 'Psilocybin for treatment-resistant depression.' New England Journal of Medicine. PMID: 34890414(https://pubmed.ncbi.nlm.nih.gov/34890414/)

Huot P, et al. (2012). 'Serotonin and Parkinson's disease.' Journal of Neural Transmission. PMID: 21893989(https://pubmed.ncbi.nlm.nih.gov/21893989/)

Ly C, et al. (2018). 'Psychedelics promote structural plasticity.' Cell Reports. PMID: 29590614(https://pubmed.ncbi.nlm.nih.gov/29590614/)

External Links

[NCBI Gene: HTR2A](https://www.ncbi.nlm.nih.gov/gene/3352)
[UniProt: HTR2A](https://www.uniprot.org/uniprot/P28223)
[Ensembl: HTR2A](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102468)
[Human Protein Atlas: HTR2A](https://www.proteinatlas.org/ENSG00000102468-HTR2A)
[IUPHAR/BPS Guide to Pharmacology: 5-HT2A](https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=49)

Background

The study of Htr2A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

[Allen Human Brain Atlas - HTR2A Expression](https://human.brain-map.org/microarray/search/show?search_term=HTR2A)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/)
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)

Expression Pattern

HTR2A shows region-specific expression in the brain:

High Expression:

Cerebral cortex (layer 5 pyramidal neurons)
Olfactory tubercle
Nucleus accumbens
Hippocampal interneurons

Cell-Type Specificity:

Expressed primarily in glutamatergic pyramidal neurons
Some expression in GABAergic interneurons
Not expressed in dopaminergic or serotonergic cell bodies

Molecular Mechanisms

The 5-HT2A receptor is a GPCR coupled to Gq proteins, activating:

Phospholipase C (PLC)
Protein kinase C (PKC)
Calcium signaling cascades
MAPK/ERK pathway

Receptor signaling regulates:

Neuronal excitability
Neurotransmitter release
Gene expression via transcription factors
Dendritic spine morphology

Role in Neurodegeneration

Alzheimer's Disease:

5-HT2A receptor density reduced in AD cortex
Role in Aβ-induced neurotoxicity
Therapeutic target for behavioral symptoms

Parkinson's Disease:

Altered 5-HT2A signaling in PD psychosis
Target for pimanserin (anti-psychotic)
Modulates L-DOPA-induced dyskinesias

Depression:

5-HT2A polymorphisms affect treatment response
Antidepressant effects of 5-HT2A antagonism

Therapeutic Targeting

| Drug | Indication | Mechanism |
|------|------------|-----------|
| Pimavanserin | PD psychosis | 5-HT2A inverse agonist |
| Ketanserin | Research | 5-HT2A antagonist |
| DOI | Research | 5-HT2A agonist |

Animal Models

5-HT2A knockout mice show:

Impaired sensorimotor gating
Reduced anxiety-like behavior
Altered psychedelic response

Research Directions

Developing biased agonists with reduced side effects
Understanding receptor heterodimerization
Biomarker development for 5-HT2A dysfunction
Role in neuroinflammation

References

[Nichols DE, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22293759/)

[Gonzalez-Maeso J, et al, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17698010/)

[Carhart-Harris RL, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34890414/)

[Huot P, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/21893989/)

[Ly C, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29590614/)

[Aghajanian GK, et al, (1990) (1990)](https://pubmed.ncbi.nlm.nih.gov/1690107/)

[Meltzer HY, et al, (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9721818/)

[Artigas F, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23147529/)

Pathway Diagram

The following diagram shows the key molecular relationships involving HTR2A Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

HTR2A Gene

HTR2A Gene

HTR2A Gene

HTR2A — Serotonin Receptor 2A

Introduction

Overview

Receptor Structure

Signal Transduction

Normal Physiological Functions

Central Nervous System

Peripheral Tissues

Brain Region Distribution

Disease Associations

Schizophrenia

Major Depressive Disorder

Parkinson's Disease

Alzheimer's Disease

Other Neurological Conditions

Therapeutic Implications

Current Therapeutics

Psychedelic-Assisted Therapy

Drug Development Challenges

Key Publications

See Also

External Links

Background

Brain Atlas Resources

Expression Pattern

Molecular Mechanisms

Role in Neurodegeneration

Therapeutic Targeting

Animal Models

Research Directions

References

Pathway Diagram